Latest

Market news by symbol, source, and language

20 stories

Kontron AG: The Executive Board and Supervisory Board recommend that shareholders do not accept the mandatory takeover offer from Ennoconn Corporation

Kontron AG/ Key word(s): StatementKontron AG: The Executive Board and Supervisory Board recommend that shareholders do not accept the mandatory takeover offer from Ennoconn Corporation08.07.2026 / 18:03 CET/CESTThe issuer is solely responsible for the content of this announcement.Linz, 8 July 2026…

EQS en_IN
corp_bondStocksDE

REG - Tata Steel Limited - Press Release

RNS Number : 5884L Tata Steel Limited 08 July 2026  Ref.: SEC/622/2026-27July 8, 2026London Stock ExchangeLondonDear Madam, Sirs,Sub: Press ReleasePlease find enclosed the press release titled 'Tata Steel: 1QFY2027 Production and Delivery Volumes (Provisional)'.This disclosure is being made in c…

London Stock Exchange en_IN
ETFsStocksIN

AUTO1 Group SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

AUTO1 Group SEAUTO1 Group SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution08.07.2026 / 18:00 CET/CESTDissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.The issuer…

EQS en_IN
StocksDE

REG - Shawbrook Group PLC - Appointment of Independent Non-Executive Director

RNS Number : 5828L Shawbrook Group PLC 08 July 2026  This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and…

London Stock Exchange en_IN
StocksGB
globenewswire

Half-Year Report on Liquidity Contract with Invest Securities

NANTES, France, July 8, 2026 – 6:00pm CET - OSE Immunotherapeutics SA ISIN:FR0012127173; Mnemo:OSE – Under the liquidity contract entrusted by OSE Immunotherapeutics to Invest Securities, the following resources were available in the liquidity account as of June 30, 2026:Over the period from 01/01…

GlobeNewswire en_IN
StocksFR

REG - HANetf ICAV ETCWEB3ACCUSD ETCWEB3ACCGBX - Important Notice to Shareholders

RNS Number : 5880L HANetf ICAV 08 July 2026  8 July 2026HANetf ICAV - Important Information - Changes to Fund CharacteristicsThe characteristics of the following ETF issued by HANetf ICAV will be modified at the Market Open on 15th July 2026ISIN: IE000KDY10O3Exchange: London Stock ExchangeShould…

London Stock Exchange en_IN
ETFs

REG - Galantas Gold Corp - Exercise of Warrants

RNS Number : 5874L Galantas Gold Corporation 08 July 2026  GALANTAS GOLD ANNOUNCES THE EXERCISE OF WARRANTSToronto, Ontario - July 8, 2026 - Galantas Gold Corporation (TSX-V: GAL | AIM: GAL) ("Galantas" or the "Company") announces the following exercises of warrants.On 7 July 2026, compensation…

London Stock Exchange en_IN
StocksCAGB

REG - Vanquis Banking Grp - Holding(s) in Company

RNS Number : 5869L Vanquis Banking Group PLC 08 July 2026  TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00B1Z4ST84Issuer NameVANQUIS BANKING GROUP PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person sub…

London Stock Exchange en_IN
StocksGB
tradingview

CHS Inc 3Q FY2026: Revenue $11.58B, Net income $267.37M — 10-Q Summary

CHS Inc reported third-quarter fiscal 2026 results with revenue of $11.58B, up from $9.77B a year earlier, and net income attributable to CHS Inc. of $267.37M, versus $232.18M in the prior-year quarter.Financial HighlightsBusiness HighlightsOriginal SEC Filing: CHS INC [ CHSCO ] - 10-Q - Jul. 08, 2…

TradingView en_IN
StocksUS